Immunotherapy for Oral Cavity Cancer

A physician-evaluated, immune-based approach for patients diagnosed with oral cavity cancer — at any stage.

Oral Cavity Cancer: Overview

Oral cavity cancer affects the lips, tongue, gums, and other structures within the mouth. Treatment often includes surgery, radiation therapy, chemotherapy, or a combination of these depending on the stage and location. Many patients continue looking for additional options — especially when the disease is advanced, recurrent, or when treatment significantly impacts daily function and quality of life.

NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.

"Oral cavity tumors may develop mechanisms to evade immune detection. Supporting NK cell function is one way to address this challenge at a systemic level."

Giostar Medical Team

Why early action is Critical

Oral cavity cancer can progress quickly — and may significantly affect essential daily functions.

Annual u.s. cases

54,000

new oral cavity and oropharyngeal cancer cases per year in the United States.

Annual u.s. deaths

11,000+

deaths attributed to oral cavity and oropharyngeal cancers in the U.S. each year.

Advanced disease may cause

Difficulty speaking

Pain when eating

Swallowing difficulties

Changes in facial structure

As the disease progresses, treatment may become more complex. Early action helps preserve function, quality of life, and available treatment pathways.

Why Consider Cellular Immunotherapy?

Natural Killer cells are part of the innate immune system and play an important role in detecting and eliminating abnormal cells. This is particularly relevant in oral cavity cancers, where tumors may develop mechanisms to evade immune detection and continue progressing despite treatment.

Nk cell mechanism

How Natural Killer Cells Target Cancer

Tumor Cell

Cancer cells evade normal immune detection

NK Recognition

NK cells detect "missing self" signals on abnormal cells

Cytotoxic Release

NK cells deploy perforin and granzymes

Cell Elimination

Tumor cell undergoes targeted aproptosis

In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.

NK Cell Therapy is designed to:

Support immune surveillance

Help the immune system recognize abnormal cells

Provide a systemic, whole-body immune approach

Complement a broader treatment strategy when medically appropriate

Are You a Candidate?

NK Cell Immunotherapy may be considered for patients who:

Have been diagnosed with oral cavity cancer

Are exploring complementary or integrative treatment options

Have advanced, recurrent, or metastatic disease

Have not responded as expected to conventional treatment

Want to support immune function during or after treatment

Are seeking a less invasive cellular therapy option

Every case is individually reviewed by our physician team to determine whether the patient is eligible.

Not all oral cavity cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.

A Comprehensive Approach

Physician-led case review

In-house cellular laboratory processing

Nutritional support

International patient coordination

Clinical process

How the Process Works

Medical Evaluation

Your diagnosis, medical history, and treatment goals are reviewed by our physicians.

Immune Profiling & Blood Collection

A blood sample is collected to isolate immune cells and assess baseline function.

NK Cell Expansion

NK cells are activated and expanded in our specialized laboratory.

Controlled Reinfusion

Expanded NK cells are administered intravenously under clinical protocols.

Monitoring & Follow-Up

Progress is tracked through advanced laboratory testing and physician follow-up.

Next Step: Medical Review

If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.